ZMZaid Rakan Mohammed

Zaid Rakan Mohammed

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Zaid Rakan Mohammed has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Thymoquinone: A Review on its Pharmacological Importance, and its Association with Oxidative Stress, COVID-19, and Radiotherapy

    by Seyithan Taysi, Firas Shawqi Algburi, Zaid Rakan Mohammed, Omeed Akbar Ali, Muhammed Enes Taysi

    Widely consumed worldwide, Nigella sativa (NS) is a medicinal herb commonly used in various alternative medicine systems, such as Unani and Tibb, Ayurveda, and Siddha. Recommended for regular use in Tibb-e-Nabwi (Prophetic Medicine), NS is considered one of the most notable forms of healing medicine in Islamic literature. Thymoquinone (TQ), the main component of the essential oil of NS, has been reported to have many properties, such as antioxidant, anti-inflammatory, antiviral, and antineoplastic. Its chemical structure indicates antiviral potential against many viruses, including the hepatitis C virus, human immunodeficiency virus, and other coronavirus diseases. Interestingly, molecular docking studies have demonstrated that TQ can potentially inhibit the development of the coronavirus disease 2019 (COVID-19) by binding to the receptor site on the transmembrane serine protease 2 (the activator enzyme that attaches the virus to the cell). In addition, TQ has been shown to be effective against cancer cells due to its inhibitory effect by binding to the different regions of MDM2, according to the proposed molecular docking study. Detailed in this review is the origin of TQ, its significance in alternative medicine, pharmacological value, potential as a cancer antiproliferative agent, use against the coronavirus disease 2019 (COVID-19) and for treatment of other diseases.


  • Open Access

    Anti-ulcer Activity of Ethanol Root Extracts of Cassia sieberiana D.C. in Albino Rats

    by H. Bello, Z. Mohammed, U. Katsayal

    Aims: The study was aimed at investigating the anti-ulcer activity of Cassia sieberiana fractionated root extracts using ethanol induction model in laboratory rats. Study Design: This is an experimental laboratory report on phytochemical screening, acute toxicity and anti-ulcer investigations that will provide scientific information on ulcerogenic potential of Cassia sieberiana root. Place and Duration of Study: The work was carried out at the Department of Pharmacognosy/ Drug Development and Department of Pharmacology, Faculty of Pharmaceutical Sciences, Ahmadu Bello University, Zaria, Nigeria from April, 2012 to February, 2013. Methodology: Cassia sieberiana root were extracted with absolute ethanol for 48 h using cold maceration method .Reconstituted in aqueous solution, fractionated with ethylacetate and butanol. The extracts were subjected to phytochemical, toxicity experiment and anti- ulcer evaluation using ethanol – induced gastric ulcer in laboratory rats. A standard anti-ulcer agent, cimetidine was used as reference. The data were analyzed by one-way Analysis of Variance at (pResults: The total solid recovered from crude extract of C. sieberiana root yielded 80 g. The extract was dark brown in color with pleasant smell and pasty inconsistency. The weight of various fractions determined were ethylacetate (14.01 g), butanol (9.98 g), Aqueous (7.80 g). Preliminary phytochemical studies revealed the presence of anthraquinone saponins, glycosides, tannins, steroid, flavonoids in the ethylacetate fraction. LD50 was above 5000 mg/kg and did not cause mortality in all the tested rats. Ethanol triggered severe gastric ulcers with mean ulcer index (53.8±2.4 mm) and pretreatment with C. sieberiana extracts of ethylacetate fraction (EAF) and n-butanol fraction (NBF) at (200, 400 and 800 mg/kg) and cimetidine (100 mg/kg) produced a significant (p < 0.05) dose dependent anti-ulcer activity with increase in percentage preventive index (72%, 91% and 100%) for EAF and (46%, 81%and 97%) for NBF fractions. cimetidine has 88% preventive index. Conclusion: This study demonstrated that C. sieberiana has anti-ulcer potentials and it justified the traditional uses of this plant root in ulcer treatment.